Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

Apr 1, 2026 04:06PM Design Therapeutics appoints David Shapiro to board of directors

Mar 16, 2026 12:53AM Jefferies Starts Design Therapeutics Inc (DSGN) at Buy

Mar 10, 2026 08:44AM 'Design Therapeutics Inc (DSGN) Remains On Track For 2H Catalysts'; PT Raised at RBC Capital

Mar 10, 2026 08:32AM Piper Sandler on Design Therapeutics Inc (DSGN): 'Execution Is Full Gear Mode With a Catalyst Rich 2H26'

Mar 9, 2026 04:19PM Design Therapeutics, Inc. (DSGN) Tops Q4 EPS by 6c

Dec 3, 2025 09:04AM Craig-Hallum Starts Design Therapeutics Inc (DSGN) at Buy

Dec 3, 2025 06:39AM Leerink Partners Upgrades Design Therapeutics Inc (DSGN) to Outperform

Nov 20, 2025 05:05AM RBC Capital Upgrades Design Therapeutics Inc (DSGN) to Outperform

Nov 5, 2025 04:03PM Design Therapeutics plans DM1 patient dosing for first half 2026

Jun 4, 2025 08:10AM RBC Capital Reiterates Sector Perform Rating on Design Therapeutics Inc (DSGN)

Jun 4, 2025 07:02AM Design Therapeutics Inc. (DSGN) Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2

May 7, 2025 06:01PM Design Therapeutics, Inc. (DSGN) Misses Q1 EPS by 2c

May 1, 2025 08:04AM Design Therapeutics Inc. (DSGN) Announces Favorable Phase 1 Data for DT-168

Apr 17, 2025 08:01AM Design Therapeutics (DSGN) Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer

Mar 10, 2025 07:08AM Design Therapeutics, Inc. (DSGN) Tops Q4 EPS by 2c

Nov 8, 2024 04:28PM Design Therapeutics, Inc. (DSGN) Tops Q3 EPS by 1c

Aug 5, 2024 03:59PM Design Therapeutics, Inc. (DSGN) Tops Q2 EPS by 2c